COVID-19

I hope the German public health authorities know of work on dead salmon recognising facial expressions

As numerous relatives have (delightedly!) pointed out, due to my recent 50th birthday, I am now sufficiently old to be in the next or next-but-one group to be vaccinated. Turns out the advantage of getting old is not wisdom, which I don’t appear to be acquiring, but moving up the vaccine queue. So I am following all news of vaccinations with interest. Currently in the news is the suspension of use of the Oxford-AstraZeneca vaccine in a number of European countries including Germany. There is information on the basis of this decision in Germany here.

Continue reading
COVID-19

Has the pandemic done for medicine what Paul Ginsparg did for physics?

It occurs to me that a lot, perhaps most, of the papers I am reading on COVID-19 research, are preprints, not articles in peer-reviewed journals. These are mostly not by physicists, who have been putting preprints on arXiv for over 20 years, but by scientists in a whole range of fields, including medicine. The biomedical research equivalent of arXiv, medRxiv, is only two years old but has been publishing a lot of COVID-19 research. arXiv has to an extent democratised research in physics, if people read arXiv preprints it matters less if the paper finally appear in the more glamorous journals like Science or Nature.

Continue reading
COVID-19

Some particles are just the right size to go through a filter, not too small and not too large

Surprisingly, it is easier to filter out (from air) particles tens of nanometres across, than it is to filter particles hundreds of nanometres across. The image above shows why. The orange and green curves show the trajectories of two particles in air flowing through a model mask. The model is a two-dimensional cross section of a mask, with cross-sections through the fibres of which surgical masks are made, shown as reddish brown discs. The blue curves with arrows show the flow of the air through the model mask. The orange trajectory illustrates one of the particles that are hardest to filter out – and so cause us some of the biggest problems when we try and stop COVID-19 transmission.

Continue reading
COVID-19

At the same time as parts of Italy were being overwhelmed by COVID-19, the UK government was downgrading the risk from COVID-19

I have been reading a couple of reports looking at the UK government’s guidance on the use of Personal Protective Equipment (PPE) for healthcare workers whose patients may be infected with COVID-19. One report by Dinah Gould and Edward Purssell was commissioned by the Royal College of Nursing and is pretty damning of the process by which the guidance was drawn up and the (lack of) evidence cited. But it is the other report, by a Health and Safety consultant David Osborn*, that astonished me when I read it Friday evening. COVID-19, the disease that has killed over 100,000 people in the UK, and millions worldwide, is not classified by the UK government as a “high consequence infectious disease” (HCID). This surprises me. Even more remarkably, it was considered a HCID until mid-March 2020, when it was downgraded. If you don’t believe me (and I wouldn’t blame you here), the official UK government page is here. If you remember, March 2020 was about the time that COVID-19 was overwhelming the healthcare system of parts of northern Italy, forcing the Italian government to send in the army. On the face of it, downgrading the official risk classification of an infectious disease at the same time as that disease is overwhelming the healthcare system of another European country is a surprising decision.

Continue reading
COVID-19

We successfully suppressed the virus – the flu virus

It has not been a good year for the world, but we have achieved one remarkable and good thing. Flu infections are at historic lows. We have successfully suppressed the flu virus. We have been less successful with the, more infectious, SARS-CoV-2 virus that causes COVID-19, but with flu we have been successful. Presumably this is simply because these two diseases, flu and COVID-19, spread in very similar ways.

Continue reading
COVID-19

In scientific research you get what you pay for

We are in the middle of a global pandemic caused by a virus, SARS-CoV-2, that is transmitted in the air we breathe. Especially in the UK it is not going well, with over 1,000 people dying a day. A big part of the problem is political. But it is also true that our knowledge of how diseases that spread in the air we breathe, is very incomplete. This is, I think, contributing to both debates and decision making being poorly done. Examples I can think of include debates and decision making in important areas such as social distancing, mask wearing, and whether in the middle of a pandemic it is a good idea to encourage people to visits restaurants. So why is our knowledge of how diseases such as COVID-19 spread, so incomplete?

Continue reading
COVID-19

Different perspectives on COVID-19’s attack rate

The attack rate of an infectious disease is the % chance that you contract it. I think it is term was introduced by epidemiologists. A high attack rate is bad of course, a lower one would be better, so we want to know what the attack rate depends on. Epidemiologists typically want to know how the attack rate depends on, for example, “age, symptom status, duration of exposure and household size” — see a recent preprint by Prof Neil Ferguson at Imperial College and coworkers. So here the questions are: Are children more likely to become infected than the elderly? Does longer contact with an infected person increase the chance of infection? And so on. Aerosol scientists such as Prof Jose Jimenez, and at least some medics, have a different perspective on what determines the attack rate. Prof Jimenez has a Google Sheets that estimates attack rates. But here the assumption (not question) is that the attack rate depends on duration, but not age, as well as on other factors such as ventilation. I am wondering about these two different perspectives on the same problem.

Continue reading
COVID-19

Scientific-looking claims for masks

One of my Christmas presents was a mask. A thoughtful present, although a mask as a Christmas present says a lot about the sort of year 2020 was. Anyway, the mask’s packaging makes a number of scientific-looking claims, and as I have been working on understanding how masks work (preprints here and here), I thought I would go through them. Maybe the manufacturer of your mask makes similar claims.

Continue reading
COVID-19

We’re all different, and that (probably) matters for infection with COVID-19

Felipe IV de castaño y plata, by Diego Velázquez

Above is Diego Velazquez’s portrait of Philip IV of Spain. He is not the best looking royal, and has what is sometimes called the Habsburg jaw, i.e., a very large jaw, attributed in this case to a lot of cousin marrying by his royal dynasty, the Habsburgs. They were rather inbred. Lab experiments on how diseases are transmitted are often done on mice. Now you might think that lab mice have little in common with the Habsburgs, but in fact they do haveone thing in common: the mice are also inbred. I think biologists want to avoid the variability that would occur if the, say, 50 lab mice they are doing experiments on, have a lot of genetic variability. So they are deliberately inbred.

Continue reading
COVID-19

When masks work, and when they don’t

With billions wearing face coverings, the question we want answered is: How effective are they at reducing the probability of you becoming infected with COVID-19? This question is very hard to answer. We can split it up into two questions: If you wear a mask, how much does this reduce the dose of virus you breathe in? And how does the chance of you becoming infected decrease, when the dose of virus you breathe in is reduced? Colleagues and I have had a go at answering the first question — preprint here. Here I will just assume that mask wearing reduces the dose by a factor of one half. This does not mean that the probability that you will become infected is reduced by one half. It is not that simple, unfortunately.

Continue reading